Latest Prostate cancer Stories
Expanding OGX-427 Clinical Development Program Demonstrates the Company's Commitment to Addressing the Challenge of Cancer Treatment Resistance BOTHELL, Wash. and VANCOUVER, British Columbia, May 22, 2013 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI), a leader in the development of novel therapeutics to target mechanisms of treatment resistance in cancer, today announced that four trials of its investigational compounds, custirsen and OGX-427, will be presented as...
Study clarifies roles of anti-angiogenic proteins in discouraging metastasis and reveals potential anti-metastasis drug BOSTON, May 21, 2013 /PRNewswire-USNewswire/ -- By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces metastatic spread in mouse models of prostate, breast and lung cancer. The findings suggest that...
Older prostate cancer patients with other underlying health conditions should think twice before committing to surgery or radiation therapy for their cancer, according to a multicenter study led by researchers in the UCLA Department of Urology. The study reports the 14-year survival outcomes of 3,000 men diagnosed with prostate cancer between 1994 and 1995. The results suggest that older patients with low- to intermediate-risk prostate cancer and who have at least three underlying health...
IASIS MEDICAL Sees Substantial Opportunity In Offering IsoRay's Entire Product Line RICHLAND, Wash., May 21, 2013 /PRNewswire/ -- IsoRay, Inc. (AMEX: ISR), (http://www.isoray.com/), announced today that it has entered into an exclusive international distribution agreement with IASIS Medical for the sale of IsoRay's complete product line in Greece. IsoRay is a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for brain cancer, lung...
Updated ASTRO Model Policy Endorses Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer SUNNYVALE, Calif., May 21, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today the publication of study results involving hundreds of prostate cancer patients treated with the CyberKnife® Robotic Radiosurgery System, the most widely used form of prostate stereotactic body radiation therapy (SBRT). The study followed 304 patients for a median of 5 years, and many...
REDWOOD CITY, Calif., May 21, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that results from ten studies in breast, colon and prostate cancer, including a large next generation sequencing (NGS) study, will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 31 - June 4, 2013 at McCormick Place in Chicago. (Logo: http://photos.prnewswire.com/prnh/20130425/SF01493LOGO) Presentations include: Results...
Join the fun and take a slice out of lung cancer at New York's SPiN Galactic! NEW YORK, May 20, 2013 /PRNewswire-USNewswire/ -- For the second year, LUNGevity Foundation, the nation's largest lung cancer-focused nonprofit, will host a unique evening of ping pong to raise money for lung cancer at SPiN Galactic in New York City on June 5, 2013. The fun-filled event is being chaired by Shannon Broder, Don McDonough, Lizzie McDonough, John Rigos, Erin Stern, and Andrew Stern. Help stop...
HMHP Foundation will host a mega car show and family fun event on Sunday, June 9. The event will raise funds for prostate cancer awareness. Boardman, Ohio (PRWEB) May 17, 2013 The HMHP Foundation is planning the first Fuel the Fight: Drive Out Prostate Cancer mega car show and family event from 10 a.m. to 3 p.m. on Sunday, June 9. The event will be held at Boardman High School, 7777 Glenwood Ave., Boardman. In case of rain, the event will be moved to Sunday, June 30. Admission to the...
Linear accelerator is island's first Versa HD PONCE, Puerto Rico, May 17, 2013 /PRNewswire/ -- Serving a region of 650,000 inhabitants in southern, central and western Puerto Rico, Caribbean Imaging and Radiation Therapy (CIRT, Ponce, PR) Center has improved its radiation therapy capabilities with the acquisition of an Elekta Versa HD(TM) system, the first in Puerto Rico. Versa HD offers clinicians the versatility to deliver conventional therapies to treat a wide range of tumors...
Genetic Testing is Surprisingly Easy and Affordable According to Author of New Gene Patch Medicine Book SAN FRANCISCO, May 17, 2013 /PRNewswire/ -- When Angelina Jolie told the world about her double mastectomy, she expressed a wish for all women with a family history of breast cancer: "It is my hope that they, too, will be able to get gene tested, and that if they have a high risk they, too, will know that they have strong options." You may think that such a test is something only...
